Ziprasidone: the fifth atypical antipsychotic

OBJECTIVE: To review the pharmacology, pharmacokinetics, clinical efficacy, and adverse effects of ziprasidone as a treatment for schizophrenia. DATA SOURCES: Information was selected from a MEDLINE search (July 2000–October 2001) of English-language medical literature using ziprasidone as the searc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Annals of pharmacotherapy 2002-05, Vol.36 (5), p.839-851
Hauptverfasser:	Caley, CF, Cooper, CK
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Antipsychotic Agents - administration & dosage Antipsychotic Agents - pharmacokinetics Antipsychotic Agents - therapeutic use Basal Ganglia Diseases - chemically induced Biological and medical sciences Body Weight - drug effects Headache - chemically induced Humans Injections, Intramuscular Long QT Syndrome - chemically induced Medical sciences Nausea - chemically induced Neuropharmacology Pharmacology. Drug treatments Piperazines - adverse effects Piperazines - pharmacokinetics Piperazines - therapeutic use Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology Randomized Controlled Trials as Topic Schizophrenia - drug therapy Thiazoles - adverse effects Thiazoles - pharmacokinetics Thiazoles - therapeutic use Treatment Outcome Weight Gain - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!